F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions. By Christina Jewett and Apoorva Mandavilli from NYT (New York Times) Health
Read more.